NICE has published draft guidance recommending prucalopride (Resolor, Movetis) as an option for the treatment of chronic constipation in women.
However, NICE has provisionally ruled that prucalopride should only be considered for women who have tried at least two different types of laxative and lifestyle changes for at least six months, but have not had relief from constipation.
A consultation on the guidance will close on 24 August with the final guidelines expected to be published in December.
Introducing Nursing Times Learning
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Click on the topics below to get started: